Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry
Ten-year outcomes for TC and EC-T were similar and excellent; six cycles of TC is an effective option in HER2-negative eBC with pN0 or pN1 and intermediate-to-high-risk disease, according to gene expression analysis.
Authors
- Marianne Just (ORCID: https://orcid.org/0009-0009-2504-7060)
- Ulrike Nitz (ORCID: https://orcid.org/0000-0003-0143-0507)
- Oleg Gluz (ORCID: https://orcid.org/0000-0001-6019-7544)
- Christian Jackisch (ORCID: https://orcid.org/0000-0001-8537-3743)
- Nadia Harbeck (ORCID: https://orcid.org/0000-0002-9744-7372)
- Christine zu Eulenburg (ORCID: https://orcid.org/0000-0001-9365-5548)
- M Christgen
- M Graeser
- Sherko Kuemmel (ORCID: https://orcid.org/0000-0001-9355-494X)
Institutions
- Witten/Herdecke University (DE)
- Universität Hamburg (DE)
- Bethesda Hospital (IN)
- Medizinische Hochschule Hannover (DE)
- MSH Medical School Hamburg – University of Applied Sciences and Medical University (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Breast Center (CH)
- Sana Klinikum Offenbach (DE)
- Kliniken Essen-Mitte (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105891
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00